Signals mentioning Reginald Men
- Honasa calls off ₹135 crore acquisition of 58% stake in Fluence Pharma
- Honasa hits 52-week high after ₹756 crore quarterly revenue, ₹90 crore PAT
- Honasa Consumer’s Q1 FY27 revenue rises 27% to Rs 756 crore; profit more than doubles
- Honasa Consumer elevates Shivang Jain as CEO of BTM Ventures
- Honasa names Shivang Jain CEO of BTM Ventures, parent of Reginald Men
- Honasa elevates Shivang Jain to CEO of BTM Ventures after majority-stake buy
- Sofina Ventures trims Honasa stake by 1.28% in Rs 177 Cr bulk deal
- Sofina offloads Rs 177 Cr Honasa stake as VC exits from listed D2C brands accelerate
- Honasa buys 58% of Fluence Pharma for Rs 135 cr, launches Honasa Health to enter VMS market
- Honasa Consumer acquires 58% of Fluence Pharma at Rs 135 cr EV, launches Honasa Health subsidiary
- Honasa buys 58% of Fluence Pharma for ₹135 Cr, enters nutraceuticals via Honasa Health
- Honasa stock hits 52-week high as FY31 plan targets Rs 5,500 cr revenue, 300K outlets
- Honasa stock hits 52-week high as FY31 roadmap targets Rs 5,500 cr revenue, 300K outlets
- Honasa targets ₹5,500 Cr revenue by FY31, more than doubling FY26 base
- Honasa Hits 52-Week High As Q4 Profit Nearly Triples, Younger Brands Drive 40%+ Growth
- Honasa Consumer hits 52-week high as Q4 profit triples, declares maiden dividend
- Honasa declares maiden ₹3/share dividend as Q4 profit triples to ₹69 crore
- Honasa declares maiden ₹3/share dividend after Q4 profit triples to ₹69.4 cr
- Honasa Q4 profit jumps 176% to ₹69 cr; Mamaearth hits 1.2 lakh outlets, declares maiden ₹3 dividend
- Honasa Q4 profit surges 178% to ₹69 cr; Mamaearth rebounds, offline hits 1.2 lakh outlets